RADIOPHARM THERANOSTICS LTD
RADXNASDAQEarnings Sep 24US Equity
$2.78▼ $0.08 (−2.80%)
🌙 After hours$2.78▲ 0.00%Regular close · extended-hours price shown1h—
24h▼ 2.8%
7d▲ 1.8%
14d▼ 10.0%
30d▼ 34.2%
1y▼ 50.0%
🏦Market Cap
$10.92B
Mid Cap
📈Revenue Growth (YoY)
+116.0%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
14.3x
Expensive
Otter Score
57
Weak
Earnings
Q1 · 2026Reported 2026-02-27Earnings Per Share
Actual
-2.25
Expected
-1.51
miss
−49.00%
YoY −17.50%
Revenue
Actual
$987.41K
Expected
$664.45K
beat
+48.60%
YoY +14.30%
Consensus estimates
Recent quarters
Q1 2026
-2.25
miss
Q3 2025
-1.78
miss
Q1 2025
-1.91
miss
Q1 2024
-14.10
—